Chemoinformaics analysis of 2-Methyl-1-hexadecanol
| Molecular Weight | 256.474 | nRot | 14 |
| Heavy Atom Molecular Weight | 220.186 | nRig | 2 |
| Exact Molecular Weight | 256.277 | nRing | 0 |
| Solubility: LogS | -3.296 | nHRing | 0 |
| Solubility: LogP | 4.269 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 53.1965 |
| nHD | 1 | BPOL | 36.1155 |
| QED | 0.452 |
| Synth | 2.059 |
| Natural Product Likeliness | 1.487 |
| NR-PPAR-gamma | 0.968 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.002 |
| HIA | 0.007 |
| CACO-2 | -4.721 |
| MDCK | 0.0000248 |
| BBB | 0.73 |
| PPB | 0.966438 |
| VDSS | 0.344 |
| FU | 0.0297697 |
| CYP1A2-inh | 0.072 |
| CYP1A2-sub | 0.28 |
| CYP2c19-inh | 0.023 |
| CYP2c19-sub | 0.363 |
| CYP2c9-inh | 0.074 |
| CYP2c9-sub | 0.981 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.157 |
| CYP3a4-inh | 0.016 |
| CYP3a4-sub | 0.035 |
| CL | 3.386 |
| T12 | 0.833 |
| hERG | 0.011 |
| Ames | 0.004 |
| ROA | 0.028 |
| SkinSen | 0.83 |
| Carcinogencity | 0.212 |
| EI | 0.987 |
| Respiratory | 0.438 |
| NR-Aromatase | 0.02 |
| Antiviral | Yes |
| Prediction | 0.735896 |